Shaver J R, O'Connor J J, Pollice M, Cho S K, Kane G C, Fish J E, Peters S P
Department of Medicine, Jefferson Medical College, Philadelphia, Pennsylvania 19107-5083, USA.
Am J Respir Crit Care Med. 1995 Oct;152(4 Pt 1):1189-97. doi: 10.1164/ajrccm.152.4.7551369.
Inflammatory reactions in the airways are thought to play an important role in asthma pathogenesis. The goal of this work was to test prospectively the hypothesis that the pulmonary inflammatory response to segmental antigen challenge is greater in allergic asthmatic (AA) subjects than in allergic nonasthmatic (ANA) subjects. A total of 46 ragweed-allergic subjects, 27 AA and 19 ANA, took part in these studies. Subjects had normal or nearly normal pulmonary function, were on no chronic medication, and were characterized as to their skin sensitivity to intradermal ragweed injection, their nonspecific responsiveness to methacholine, and the presence (or absence) of a late asthmatic response after whole-lung antigen challenge. Subjects then underwent bronchoscopy, bronchoalveolar lavage (BAL) of a control lung segment, antigen lung challenge of a contralateral lung segment with 5 ml of a concentration of ragweed solution 100-fold higher than that required to produce a positive skin reaction, and finally, BAL of the challenged segment after 24 h. AA did not differ from ANA in any inflammatory parameter measured in BAL fluid (total cells/ml, macrophages/ml, lymphocytes/ml, eosinophils/ml, neutrophils/ml, total protein, albumin, urea, or eosinophil cationic protein) 24 h after challenge. In addition, there was no relationship between nonspecific bronchial responsiveness to methacholine and eosinophils recruited to the lung by segmental antigen challenge. Rather, in both groups a marked inflammatory response was seen only in the subgroup of subjects who demonstrated a late airway reaction after whole-lung antigen challenge, regardless of disease classification.(ABSTRACT TRUNCATED AT 250 WORDS)
气道中的炎症反应被认为在哮喘发病机制中起重要作用。这项研究的目的是前瞻性地验证以下假设:过敏性哮喘(AA)患者对节段性抗原激发的肺部炎症反应比过敏性非哮喘(ANA)患者更强。共有46名豚草过敏受试者参与了这些研究,其中27名AA患者和19名ANA患者。受试者肺功能正常或接近正常,未服用慢性药物,并根据其对皮内注射豚草的皮肤敏感性、对乙酰甲胆碱的非特异性反应性以及全肺抗原激发后迟发性哮喘反应(有无)进行了特征描述。然后,受试者接受支气管镜检查,对一个对照肺段进行支气管肺泡灌洗(BAL),用5毫升浓度比产生阳性皮肤反应所需浓度高100倍的豚草溶液对另一侧肺段进行抗原激发,最后在24小时后对激发段进行BAL。激发后24小时,在BAL液中测量的任何炎症参数(每毫升总细胞数、每毫升巨噬细胞数、每毫升淋巴细胞数、每毫升嗜酸性粒细胞数、每毫升中性粒细胞数、总蛋白、白蛋白、尿素或嗜酸性粒细胞阳离子蛋白)方面,AA组与ANA组没有差异。此外,对乙酰甲胆碱的非特异性支气管反应性与节段性抗原激发后募集到肺部的嗜酸性粒细胞之间没有关系。相反,在两组中,仅在全肺抗原激发后出现迟发性气道反应的受试者亚组中观察到明显的炎症反应,而与疾病分类无关。(摘要截断于250字)